Triazole derivatives II

Details for Australian Patent Application No. 2007252021 (hide)

Owner Merck Patent GmbH

Inventors Sirrenberg, Christian; Wolf, Michael; Eggenweiler, Hans-Michael; Buchstaller, Hans-Peter

Agent Davies Collison Cave

Pub. Number AU-B-2007252021

PCT Pub. Number WO2007/134678

Priority 10 2006 023 337.9 18.05.06 DE

Filing date 20 April 2007

Wipo publication date 29 November 2007

Acceptance publication date 7 June 2012

International Classifications

C07D 249/08 (2006.01) Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

A61K 31/4196 (2006.01) - 1,2,4-Triazoles

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

8 January 2009 PCT application entered the National Phase

  PCT publication WO2007/134678 Priority application(s): WO2007/134678

7 June 2012 Application Accepted

  Published as AU-B-2007252021

4 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007252024-Screw anchor

2007252020-1,5-diphenylpyrazoles II as HSP90 inhibitors